A recent study published in the Journal of Affective Disorders sheds light on the long-term outcomes of using ketamine to treat mood disorders like major depressive disorder and bipolar disorder. The research examined whether individuals who participated in controlled ketamine clinical trials went on to use ketamine or its derivative, esketamine, after leaving the trial, and assessed their current mental health status. Mood disorders, such as major depressive disorder and bipolar disorder, significantly impact daily functioning and overall well-being. While existing treatments—including medica…